Literature DB >> 10216418

[Iatrogenic medication: estimation of its prevalence in French public hospitals. Regional Centers of Pharmacovigilance].

J L Imbs1, P Pouyanne, F Haramburu, M Welsch, N Decker, J P Blayac, B Bégaud.   

Abstract

The French network of Regional Centres of Pharmacovigilance has made an estimation of the occurrence of adverse drug reactions in a representative sample of patients in French public hospitals (departments of medicine, of surgery and of geriatrics). The study looked at one specific day in the spring of 1997. Each observed case of adverse drug reaction was validated. The total sample comprised 2132 patients of whom 969 were in a university hospital and 1163 in a general hospital. The hospitals and units concerned are representative of the country as a whole. One adverse drug reaction at least was present for 221 patients on the day of the investigation. This means a prevalence rate of 10.3 per cent (95 per cent CI: 8.7 to 11.9 per cent). In 33 per cent of cases (95 per cent CI: 26 to 42 per cent), the observed effects were rated as serious. From an incidence rate of 1.8 per cent (95 per cent CI: 1.0 to 25 per cent) on one specified day it can be estimated that in France an adverse drug reaction will occur in about 1,300,000 patients per year during a stay in hospital.

Entities:  

Mesh:

Year:  1999        PMID: 10216418

Source DB:  PubMed          Journal:  Therapie        ISSN: 0040-5957            Impact factor:   2.070


  20 in total

1.  Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres.

Authors:  P Pouyanne; F Haramburu; J L Imbs; B Bégaud
Journal:  BMJ       Date:  2000-04-15

2.  An ABC of drug-related problems.

Authors:  R H Meyboom; M Lindquist; A C Egberts
Journal:  Drug Saf       Date:  2000-06       Impact factor: 5.606

Review 3.  Methods and systems to detect adverse drug reactions in hospitals.

Authors:  P A Thürmann
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

4.  Are incorrectly used drugs more frequently involved in adverse drug reactions? A prospective study.

Authors:  A P Jonville-Béra; F Béra; E Autret-Leca
Journal:  Eur J Clin Pharmacol       Date:  2005-04-12       Impact factor: 2.953

5.  Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital.

Authors:  Stephanie Lugardon; Karine Desboeuf; Pierre Fernet; Jean-Louis Montastruc; Maryse Lapeyre-Mestre
Journal:  Br J Clin Pharmacol       Date:  2006-08       Impact factor: 4.335

6.  Infovigilance: reporting errors in official drug information sources.

Authors:  Isabelle Fusier; Corinne Tollier; Marie-Caroline Husson
Journal:  Pharm World Sci       Date:  2005-06

7.  Assessing the feasibility of using an adverse drug reaction preventability scale in clinical practice: a study in a French emergency department.

Authors:  Pascale Olivier; Olivier Boulbés; Marie Tubery; Dominique Lauque; Jean-Louis Montastruc; Maryse Lapeyre-Mestre
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

8.  Potentially inappropriate medications and adverse drug reactions in the elderly: a study in a PharmacoVigilance database.

Authors:  François Montastruc; Cannelle Duguet; Vanessa Rousseau; Haleh Bagheri; Jean-Louis Montastruc
Journal:  Eur J Clin Pharmacol       Date:  2014-06-14       Impact factor: 2.953

Review 9.  The role of the clinical pharmacologist in the management of adverse drug reactions.

Authors:  N Moore
Journal:  Drug Saf       Date:  2001-01       Impact factor: 5.606

10.  Detection of adverse drug reactions in a neurological department: comparison between intensified surveillance and a computer-assisted approach.

Authors:  Petra A Thuermann; Roland Windecker; Joachim Steffen; Markus Schaefer; Ute Tenter; Erich Reese; Hermann Menger; Klaus Schmitt
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.